Advertisement
<< Back To Article
Enanta&#8217;s New NS5A Inhibitor Shows Early Promise Against Hep C

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Zsuzsanna Snarey

I am very hopeful that this drug will be available soon and will not be priced too high for NHS England. A single dose to cure me seems like the perfect answer. I have Hepatitis C genotype 1b and I have mild Fibrosis. F1-2. Fibroscan 8.1 This means that I do not deserve treatment until I develop cirrhosis. This seems very unfair!

October 25, 2015 Sandwich

Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.